Study Stopped
Funding withdrawn.
Manuka Honey Nasal Rinse Study
Effectiveness of Manuka Honey/Saline Nasal Rinses as an Adjunct to Standard Medical Therapy for Chronic Rhinosinusitis: A Prospective Clinical Trial
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate whether high-volume nasal rinses with a manuka honey/saline mixture will improve symptom scores, nasal endoscopic findings and CT scan findings compared to nasal saline rinse without manuka honey in patients with chronic rhinosinusitis. Manuka honey is a honey made from bees that drink the nectar from tea (manuka) trees in New Zealand. It has been shown to have antibacterial activity against common bacteria that cause chronic sinusitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2014
CompletedFirst Posted
Study publicly available on registry
March 27, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedApril 27, 2020
April 1, 2020
1.6 years
March 24, 2014
April 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in SNOT-22 Symptomatic Scores at 1 month
There are 22 questions, each scored 0 - 5. Possible scores are 0 - 110. The best score is 0, the worst score is 110.
Change from baseline at 1 month
Change in SNOT-22 Symptomatic Scores at 3 months
There are 22 questions, each scored 0 - 5. Possible scores are 0 - 110. The best score is 0, the worst score is 110.
Change from baseline at 3 months
Change in SNOT-22 Symptomatic Scores at 6 months
There are 22 questions, each scored 0 - 5. Possible scores are 0 - 110. The best score is 0, the worst score is 110.
Change from baseline at 6 months
Secondary Outcomes (4)
Change in Endoscopic Scores of CRS severity in the different treatment arms at 1 month
Change in baseline at 1 month
Change in Endoscopic Scores of CRS severity in the different treatment arms at 3 months
Change in baseline at 3 months
Change in Endoscopic Scores of CRS severity in the different treatment arms at 6 months
Change in baseline at 6 months
Change in Radiologic Scores of CRS severity in the different treatment arms at 3 months
Change in baseline at 3 months
Study Arms (2)
NeilMed Saline Sinus Rinse
ACTIVE COMPARATORSaline nasal rinses will be performed using a NeilMed® Sinus Rinse 240 ml bottle and one NeilMed® packet containing sodium chloride/sodium bicarbonate at a concentration to make an isotonic solution when mixed with distilled or previously boiled water.
Saline mixed with Manuka Honey
ACTIVE COMPARATORSaline mixed with MH nasal rinses participants will be instructed how to mix a rounded teaspoon of MH (Wedderspoon® 100% Raw Manuka Honey Active 16+) with 4-6 oz of lukewarm distilled or previously boiled water, to add along with distilled or previously boiled water and the NeilMed® Sinus Rinse packet to the rinse bottle to a final volume of 240 ml. Participants will be instructed to rinse slowly with the MH/saline rinse mixture to maximize contact time with the MH/saline mixture.
Interventions
Saline mixed with MH nasal rinses participants will be instructed how to mix a rounded teaspoon of MH (Wedderspoon® 100% Raw Manuka Honey Active 16+) with 4-6 oz of lukewarm distilled or previously boiled water, to add along with distilled or previously boiled water and the NeilMed® Sinus Rinse packet to the rinse bottle to a final volume of 240 ml. Participants will be instructed to rinse slowly with the MH/saline rinse mixture to maximize contact time with the MH/saline mixture.
Saline nasal rinses will be performed using a NeilMed® Sinus Rinse 240 ml bottle and one NeilMed® packet containing sodium chloride/sodium bicarbonate at a concentration to make an isotonic solution when mixed with distilled or previously boiled water.
Eligibility Criteria
You may qualify if:
- Chronic Rhinosinusitis
- Nasal Polyposis stages 1-3
You may not qualify if:
- Nasal Polyposis stage 4-5
- Cystic Fibrosis
- Immunocompromised patients
- Allergy to bees or honey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- NeilMed Pharmaceuticalscollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Leon, MD
University of Florida, Department of Otolaryngology
- PRINCIPAL INVESTIGATOR
Elizabeth Leon, MD
Malcom Randall VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2014
First Posted
March 27, 2014
Study Start
May 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
April 27, 2020
Record last verified: 2020-04